Nuveen Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$17.6M Sell
373,229
-9,947
-3% -$468K 0.01% 1260
2024
Q3
$20.2M Buy
383,176
+28,035
+8% +$1.48M 0.01% 1190
2024
Q2
$19.2M Sell
355,141
-144,460
-29% -$7.83M 0.01% 1157
2024
Q1
$35M Buy
499,601
+156,000
+45% +$10.9M 0.01% 822
2023
Q4
$28.7M Sell
343,601
-26,023
-7% -$2.17M 0.01% 915
2023
Q3
$10.9M Buy
369,624
+2,462
+0.7% +$72.5K ﹤0.01% 1427
2023
Q2
$12M Buy
367,162
+22,253
+6% +$726K ﹤0.01% 1388
2023
Q1
$12.1M Sell
344,909
-14,697
-4% -$517K ﹤0.01% 1363
2022
Q4
$16.5M Sell
359,606
-2,747
-0.8% -$126K 0.01% 1171
2022
Q3
$17.6M Buy
362,353
+1,344
+0.4% +$65.1K 0.01% 1108
2022
Q2
$14.2M Buy
361,009
+102,426
+40% +$4.02M 0.01% 1283
2022
Q1
$9.2M Sell
258,583
-1,707
-0.7% -$60.7K ﹤0.01% 1697
2021
Q4
$9.51M Sell
260,290
-22,259
-8% -$814K ﹤0.01% 1727
2021
Q3
$9.58M Buy
282,549
+25,117
+10% +$851K ﹤0.01% 1812
2021
Q2
$5.1M Sell
257,432
-38,434
-13% -$761K ﹤0.01% 2237
2021
Q1
$6.88M Sell
295,866
-73,338
-20% -$1.71M ﹤0.01% 2001
2020
Q4
$7.67M Sell
369,204
-175,396
-32% -$3.64M ﹤0.01% 1863
2020
Q3
$11.8M Buy
544,600
+247,892
+84% +$5.37M ﹤0.01% 1414
2020
Q2
$6.99M Buy
296,708
+50,165
+20% +$1.18M ﹤0.01% 1711
2020
Q1
$2.91M Buy
246,543
+492
+0.2% +$5.8K ﹤0.01% 2007
2019
Q4
$2.61M Sell
246,051
-174,381
-41% -$1.85M ﹤0.01% 2317
2019
Q3
$4.79M Buy
420,432
+224,569
+115% +$2.56M ﹤0.01% 1978
2019
Q2
$2.2M Buy
+195,863
New +$2.2M ﹤0.01% 2388